Keyword Index

Browse for an article via relevant keywords across our entire electronic archive

Search results for: I
Results 41 - 50 of 403 shown below

  • IGF-II

    N E Allen, A W Roddam, D S Allen, I S Fentiman, I dos Santos Silva, J Peto, J M P Holly and T J Key

    A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk

    advance online publication, 2005-03-08 00:00:00.000;

    doi:10.1038/sj.bjc.6602471

  • K Szepeshazi, A V Schally, K Groot, P Armatis, G Halmos, F Hebert, B Szende, J L Varga and M Zarandi

    Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers

    doi:10.1054/bjoc.2000.1223

  • M Oya and W A Schulz

    Decreased expression of p57KIP2mRNA in human bladder cancer

    doi:10.1054/bjoc.2000.1298

  • A G Renehan, J Jones, C S Potten, S M Shalet and S T O'Dwyer

    Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer

    doi:10.1054/bjoc.2000.1462

  • IGF-II IGF-IR

    S-B Catrina, M Lewitt, C Massambu, A Dricu, J Grünler, M Axelson, P Biberfeld and K Brismar

    Insulin-like growth factor-I receptor activity is essential for Kaposi's sarcoma growth and survival

    advance online publication, 2005-04-05 00:00:00.000;

    doi:10.1038/sj.bjc.6602408

  • IGF-system

    S I Helle, J Geisler, G B Anker, B Leirvaag, J M P Holly and P E Lønning

    Alterations in the insulin-like growth factor system during treatment with diethylstilboestrol in patients with metastatic breast cancer

    doi:10.1054/bjoc.2001.1871

  • IGF1

    K DeLellis, S Ingles, L Kolonel, R McKean-Cowdin, B Henderson, F Stanczyk and N M Probst-Hensch

    IGF1 genotype, mean plasma level and breast cancer risk in the Hawaii/Los Angeles multiethnic cohort

    doi:10.1038/sj.bjc.6600728

  • E Deutsch, L Maggiorella, B Wen, M L Bonnet, K Khanfir, V Frascogna, A G Turhan and J Bourhis

    Tyrosine kinase inhibitor AG1024 exerts antileukaemic effects on STI571-resistant Bcr-Abl expressing cells and decreases AKT phosphorylation

    advance online publication, 2004-10-19 00:00:00.000;

    doi:10.1038/sj.bjc.6602190

  • IGF1 genotype

    H Jernström, T Sandberg, E Bågeman, Å Borg and H Olsson

    Insulin-like growth factor-1 (IGF1) genotype predicts breast volume after pregnancy and hormonal contraception and is associated with circulating IGF-1 levels: implications for risk of early-onset breast cancer in young women from hereditary breast

    advance online publication, 2005-03-01 00:00:00.000;

    doi:10.1038/sj.bjc.6602389

  • E Bågeman, C Ingvar, C Rose and H Jernström

    Absence of the common Insulin-like growth factor-1 19-repeat allele is associated with early age at breast cancer diagnosis in multiparous women

    advance online publication, 2007-02-20 00:00:00.000;

    doi:10.1038/sj.bjc.6603632

  • IGFBP-3

    D Gunnell, S E Oliver, T J Peters, J L Donovan, R Persad, M Maynard, D Gillatt, A Pearce, F C Hamdy, D E Neal and J M P Holly

    Are diet–prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men

    doi:10.1038/sj.bjc.6600946

  • N E Allen, A W Roddam, D S Allen, I S Fentiman, I dos Santos Silva, J Peto, J M P Holly and T J Key

    A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk

    advance online publication, 2005-03-08 00:00:00.000;

    doi:10.1038/sj.bjc.6602471

  • F Canzian, J D McKay, R J Cleveland, L Dossus, C Biessy, S Rinaldi, S Landi, C Boillot, S Monnier, V Chajès, F Clavel-Chapelon, B Téhard, J Chang-Claude, J Linseisen, P H Lahmann, T Pischon, D Trichopoulos, A Trichopoulou, D Zilis, D Palli, R Tumino, P Vineis, F Berrino, H B Bueno-de-Mesquita, C H van Gils, P H M Peeters, G Pera, E Ardanaz, M-D Chirlaque, J R Quirós, N Larrañaga, C Martínez-García, N E Allen, T J Key, S A Bingham, K-T Khaw, N Slimani, T Norat, E Riboli and R Kaaks

    Polymorphisms of genes coding for insulin-like growth factor 1 and its major binding proteins, circulating levels of IGF-I and IGFBP-3 and breast cancer risk: results from the EPIC study

    advance online publication, 2006-01-10 00:00:00.000;

    doi:10.1038/sj.bjc.6602936

  • N M Probst-Hensch, J-M Yuan, F Z Stanczyk, Y-T Gao, R K Ross and M C Yu

    IGF-1, IGF-2 and IGFBP-3 in prediagnostic serum: association with colorectal cancer in a cohort of Chinese men in Shanghai

    doi:10.1054/bjoc.2001.2172

  • IGFBP-6

    H Koike, K Ito, Y Takezawa, T Oyama, H Yamanaka and K Suzuki

    Insulin-like growth factor binding protein-6 inhibits prostate cancer cell proliferation: implication for anticancer effect of diethylstilbestrol in hormone refractory prostate cancer

    doi:10.1038/sj.bjc.6602520

  • IGFBP-rP2

    P Vorwerk, H Wex, B Hohmann, Y Oh, R G Rosenfeld and U Mittler

    CTGF (IGFBP-rP2) is specifically expressed in malignant lymphoblasts of patients with acute lymphoblastic leukaemia (ALL)

    doi:10.1054/bjoc.2000.1364

  • IgG subclasses

    W Anderhuber, W Steinschifter, E Schauenstein, A Gotschuli, W Habermann, M Fischer and P Felsner

    The IgG1/G2 subclass shift - a sensitive, tissue non-specific marker for malignancy. Diagnostic performance with squamous cell carcinoma of the head and neck

    doi:10.1038/sj.bjc.6690283

  • IgG uptake

    C de Lange Davies, B Ø Engesæter, I Haug, I W Ormberg, J Halgunset and C Brekken

    Uptake of IgG in osteosarcoma correlates inversely with interstitial fluid pressure, but not with interstitial constituents

    doi:10.1054/bjoc.2001.2180